TODD ROSENGART to Myocytes, Cardiac
This is a "connection" page, showing publications TODD ROSENGART has written about Myocytes, Cardiac.
Connection Strength
4.691
-
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Sci Rep. 2022 07 06; 12(1):11416.
Score: 0.502
-
Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming. J Am Heart Assoc. 2021 12 21; 10(24):e022659.
Score: 0.482
-
Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming. J Am Heart Assoc. 2020 06 16; 9(12):e015686.
Score: 0.434
-
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells. J Thorac Cardiovasc Surg. 2018 08; 156(2):556-565.e1.
Score: 0.374
-
Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on. J Thorac Cardiovasc Surg. 2018 04; 155(4):1642-1646.
Score: 0.367
-
Heart regeneration: The endothelial cell comes first. J Thorac Cardiovasc Surg. 2018 03; 155(3):1128-1129.
Score: 0.361
-
Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail. J Thorac Cardiovasc Surg. 2017 11; 154(5):1601-1610.e3.
Score: 0.354
-
MiR-590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte-Like Fate by Directly Repressing Specificity Protein 1. J Am Heart Assoc. 2016 11 10; 5(11).
Score: 0.339
-
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration. J Thorac Cardiovasc Surg. 2017 02; 153(2):329-339.e3.
Score: 0.336
-
Less may be more: Using small molecules to reprogram human cells into functional cardiomyocytes. J Thorac Cardiovasc Surg. 2017 01; 153(1):128-130.
Score: 0.335
-
"Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1656-1664.e2.
Score: 0.283
-
Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1041-9; discussion 1049-51.
Score: 0.141
-
Fibroblast transition to an endothelial "trans" state improves cell reprogramming efficiency. Sci Rep. 2021 11 19; 11(1):22605.
Score: 0.120
-
Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes. Cell Reprogram. 2018 02; 20(1):27-37.
Score: 0.092
-
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012 Dec; 1(6):e005652.
Score: 0.065
-
Vascular endothelial growth factor before cells. J Thorac Cardiovasc Surg. 2005 Mar; 129(3):696.
Score: 0.038
-
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential. Sci Rep. 2024 10 15; 14(1):24182.
Score: 0.037
-
Direct cardiac reprogramming: A new technology for cardiac repair. J Mol Cell Cardiol. 2023 05; 178:51-58.
Score: 0.033